Dan Feng
Clinical trials sponsored by Dan Feng, explained in plain language.
-
New hope for Hard-to-Treat colorectal cancer: immunotherapy before liver surgery
Disease control Recruiting nowThis study tests whether giving immunotherapy before surgery can help people with a common type of colorectal cancer (MSS) that has spread to the liver. About 24 participants will receive the drug dupilumab before their liver surgery. The goal is to see if this approach is safe a…
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New immunotherapy cocktail takes on stubborn colorectal cancer
Disease control Recruiting nowThis early-phase trial is testing whether combining two immunotherapy drugs—nadunolimab and toripalimab—can help people with metastatic colorectal cancer that no longer responds to chemotherapy. The study will enroll 24 participants and first check for safety, then measure how ma…
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC